Indication Taxonomy Review
19 therapeutic areas, 158 indications
Coverage: 79,579 / 261,422 condition mentions matched (30.4%)
Oncology
40 indications 34,281 trials
Solid Tumor (Advanced) (4,735 trials)
Breast Cancer (3,104 trials)
NSCLC (2,436 trials)
Colorectal Cancer (1,881 trials)
Prostate Cancer (1,618 trials)
Non-Hodgkin Lymphoma (1,610 trials)
Multiple Myeloma (1,454 trials)
Melanoma (1,159 trials)
AML (1,146 trials)
Head and Neck Cancer (1,072 trials)
Pancreatic Cancer (1,019 trials)
Hepatocellular Carcinoma (999 trials)
Ovarian Cancer (996 trials)
MDS (859 trials)
Gastric Cancer (816 trials)
Glioblastoma (757 trials)
Lung Cancer (General) (740 trials)
Sarcoma (631 trials)
Bladder Cancer (627 trials)
Esophageal Cancer (623 trials)
Hematologic Malignancies (563 trials)
Renal Cell Carcinoma (523 trials)
CLL (499 trials)
Cholangiocarcinoma (442 trials)
ALL (414 trials)
Cervical Cancer (397 trials)
Endometrial Cancer (380 trials)
Triple Negative Breast Cancer (366 trials)
Brain Tumor (341 trials)
SCLC (322 trials)
Hodgkin Lymphoma (277 trials)
Myelofibrosis (245 trials)
Neuroendocrine Tumors (240 trials)
CML (196 trials)
HER2+ Breast Cancer (169 trials)
Mesothelioma (154 trials)
Squamous Cell Carcinoma (152 trials)
Thyroid Cancer (142 trials)
HER2- Breast Cancer (104 trials)
Merkel Cell Carcinoma (73 trials)
CNS
18 indications 8,370 trials
Major Depression (1,392 trials)
Alzheimer's Disease (1,375 trials)
Schizophrenia (847 trials)
Parkinson's Disease (743 trials)
Multiple Sclerosis (548 trials)
Alcohol Use Disorder (446 trials)
Opioid Use Disorder (414 trials)
Migraine (365 trials)
Anxiety (322 trials)
Autism Spectrum Disorder (321 trials)
Epilepsy (310 trials)
ALS (290 trials)
Bipolar Disorder (271 trials)
ADHD (239 trials)
PTSD (228 trials)
Huntington's Disease (102 trials)
Neuropathy (93 trials)
OCD (64 trials)
Metabolic
7 indications 7,428 trials
Type 2 Diabetes (2,620 trials)
Obesity (1,596 trials)
Diabetes (General) (973 trials)
Type 1 Diabetes (794 trials)
Dyslipidemia (536 trials)
Diabetic Complications (487 trials)
NASH/NAFLD (422 trials)
Infectious Disease
13 indications 6,820 trials
COVID-19 (1,950 trials)
HIV (1,327 trials)
Influenza (800 trials)
Hepatitis C (692 trials)
Hepatitis B (483 trials)
Sepsis (481 trials)
Malaria (369 trials)
Tuberculosis (285 trials)
H. pylori (155 trials)
Bacterial Infections (114 trials)
Fungal Infections (85 trials)
RSV (73 trials)
C. difficile (6 trials)
Cardiovascular
9 indications 5,078 trials
Hypertension (1,410 trials)
Stroke (904 trials)
Coronary Artery Disease (903 trials)
Heart Failure (842 trials)
Atrial Fibrillation (358 trials)
Myocardial Infarction (298 trials)
Thrombosis (272 trials)
Arrhythmia (56 trials)
Hypertrophic Cardiomyopathy (35 trials)
Immunology
15 indications 4,668 trials
Rheumatoid Arthritis (968 trials)
Psoriasis (851 trials)
Atopic Dermatitis (735 trials)
Crohn's Disease (477 trials)
Ulcerative Colitis (413 trials)
Lupus (324 trials)
Psoriatic Arthritis (129 trials)
Myasthenia Gravis (127 trials)
Lupus Nephritis (116 trials)
Hidradenitis Suppurativa (109 trials)
IgA Nephropathy (102 trials)
Chronic Spontaneous Urticaria (95 trials)
Ankylosing Spondylitis (88 trials)
IBD (81 trials)
NMOSD (53 trials)
Respiratory
7 indications 3,266 trials
Asthma (1,225 trials)
COPD (920 trials)
Cystic Fibrosis (431 trials)
Idiopathic Pulmonary Fibrosis (261 trials)
Allergic Rhinitis (195 trials)
Pneumonia (170 trials)
Chronic Rhinosinusitis with Nasal Polyps (64 trials)
Pain
4 indications 2,677 trials
Acute Pain (1,288 trials)
Postoperative Pain (975 trials)
Chronic Pain (275 trials)
Neuropathic Pain (139 trials)
Rare Disease
9 indications 1,076 trials
Sickle Cell Disease (357 trials)
Hemophilia (239 trials)
Immune Thrombocytopenia (190 trials)
Duchenne Muscular Dystrophy (140 trials)
Fabry Disease (61 trials)
Spinal Muscular Atrophy (44 trials)
Gaucher Disease (26 trials)
Mastocytosis (15 trials)
CDKL5 Deficiency Disorder (4 trials)
Women's Health
5 indications 1,031 trials
Infertility (361 trials)
Contraception (191 trials)
PCOS (176 trials)
Menopause (161 trials)
Endometriosis (142 trials)
Musculoskeletal
4 indications 821 trials
Osteoarthritis (291 trials)
Osteoporosis (275 trials)
Gout (203 trials)
Muscle Spasm (52 trials)
Ophthalmology
3 indications 770 trials
Dry Eye (341 trials)
Glaucoma (265 trials)
Age-Related Macular Degeneration (164 trials)
Renal
2 indications 770 trials
Chronic Kidney Disease (584 trials)
Acute Kidney Injury (186 trials)
Dermatology
5 indications 740 trials
Acne (356 trials)
Alopecia (195 trials)
Vitiligo (74 trials)
Rosacea (72 trials)
Skin Infections (43 trials)
Gastrointestinal
5 indications 634 trials
Nausea/Vomiting (166 trials)
Constipation (162 trials)
GERD (126 trials)
Diarrhea (114 trials)
Peptic Ulcer (66 trials)
Urology
3 indications 488 trials
Overactive Bladder (222 trials)
Erectile Dysfunction (164 trials)
Benign Prostatic Hyperplasia (102 trials)
Hepatology
2 indications 280 trials
Cirrhosis (231 trials)
Liver Failure (49 trials)
Sleep
2 indications 216 trials
Insomnia (176 trials)
Narcolepsy (40 trials)
Endocrine
5 indications 165 trials
Acromegaly (49 trials)
Growth Hormone Deficiency (41 trials)
Hypothyroidism (25 trials)
Hyperthyroidism (25 trials)
Adrenal Insufficiency (25 trials)
How to use: Review each therapeutic area and its indications. Click "▼ aliases" to see which condition names map to each canonical indication.
Zero counts: Gray aliases haven't been seen in trial data yet (may be rare or spelling variations).
Edit taxonomy: scripts/indication-taxonomy.js